K H Rand|T C Merigan - JoVE Visualize

Showing results (281-290 of 295) with videos related to

Pageof 30

Sort By:

Cancer|January 15, 1984

Prophylaxis of fever and infection in adult cancer patients. A placebo-controlled trial of oral trimethoprim-sulfamethoxazole plus erythromycinB S Kramer, D J Carr, K H Rand, et al.

AIDS Research and Human Retroviruses|October 6, 2000

Highly active antiretroviral therapy results in HIV type 1 suppression in lymph nodes, increased pools of naive T cells, decreased pools of activated T cells, and diminished frequencies of peripheral activated HIV type 1-specific CD8+ T cellsC M Gray, J Lawrence, E A Ranheim, et al.

Circulation|July 7, 1999

Impact of prophylactic immediate posttransplant ganciclovir on development of transplant atherosclerosis: a post hoc analysis of a randomized, placebo-controlled studyH A Valantine, S Z Gao, S G Menon, et al.

The New England Journal of Medicine|October 10, 1996

The relation of virologic and immunologic markers to clinical outcomes after nucleoside therapy in HIV-infected adults with 200 to 500 CD4 cells per cubic millimeter. AIDS Clinical Trials Group Study 175 Virology Study TeamD A Katzenstein, S M Hammer, M D Hughes, et al.

Annals of Internal Medicine|July 1, 1982

Cytomegalovirus immune plasma in bone marrow transplant recipientsD J Winston, R B Pollard, W G Ho, et al.

Open Forum Infectious Diseases|August 30, 2021

Relationship of Multiplex Molecular Pneumonia Panel Results With Hospital Outcomes and Clinical VariablesK H Rand, S G Beal, K Cherabuddi, et al.

Journal of Clinical Microbiology|January 1, 1990

Three-year experience with sonicated vascular catheter cultures in a clinical microbiology laboratoryR J Sherertz, I I Raad, A Belani, et al.

Antimicrobial Agents and Chemotherapy|May 11, 1992

Vancomycin is not an essential component of the initial empiric treatment regimen for febrile neutropenic patients receiving ceftazidime: a randomized prospective studyR Ramphal, M Bolger, D J Oblon, et al.

The New England Journal of Medicine|October 10, 1996

A trial comparing nucleoside monotherapy with combination therapy in HIV-infected adults with CD4 cell counts from 200 to 500 per cubic millimeter. AIDS Clinical Trials Group Study 175 Study TeamS M Hammer, D A Katzenstein, M D Hughes, et al.

AIDS (London, England)|July 14, 2000

A randomized study of antiretroviral management based on plasma genotypic antiretroviral resistance testing in patients failing therapy. CPCRA 046 Study Team for the Terry Beirn Community Programs for Clinical Research on AIDSJ D Baxter, D L Mayers, D N Wentworth, et al.

Pageof 30

Showing results (281-290 of 295) with videos related to

Sort By:

Pageof 30

Cancer|January 15, 1984

Prophylaxis of fever and infection in adult cancer patients. A placebo-controlled trial of oral trimethoprim-sulfamethoxazole plus erythromycinB S Kramer, D J Carr, K H Rand, et al.

AIDS Research and Human Retroviruses|October 6, 2000

Highly active antiretroviral therapy results in HIV type 1 suppression in lymph nodes, increased pools of naive T cells, decreased pools of activated T cells, and diminished frequencies of peripheral activated HIV type 1-specific CD8+ T cellsC M Gray, J Lawrence, E A Ranheim, et al.

Circulation|July 7, 1999

Impact of prophylactic immediate posttransplant ganciclovir on development of transplant atherosclerosis: a post hoc analysis of a randomized, placebo-controlled studyH A Valantine, S Z Gao, S G Menon, et al.

The New England Journal of Medicine|October 10, 1996

The relation of virologic and immunologic markers to clinical outcomes after nucleoside therapy in HIV-infected adults with 200 to 500 CD4 cells per cubic millimeter. AIDS Clinical Trials Group Study 175 Virology Study TeamD A Katzenstein, S M Hammer, M D Hughes, et al.

Annals of Internal Medicine|July 1, 1982

Cytomegalovirus immune plasma in bone marrow transplant recipientsD J Winston, R B Pollard, W G Ho, et al.

Open Forum Infectious Diseases|August 30, 2021

Relationship of Multiplex Molecular Pneumonia Panel Results With Hospital Outcomes and Clinical VariablesK H Rand, S G Beal, K Cherabuddi, et al.

Journal of Clinical Microbiology|January 1, 1990

Three-year experience with sonicated vascular catheter cultures in a clinical microbiology laboratoryR J Sherertz, I I Raad, A Belani, et al.

Antimicrobial Agents and Chemotherapy|May 11, 1992

Vancomycin is not an essential component of the initial empiric treatment regimen for febrile neutropenic patients receiving ceftazidime: a randomized prospective studyR Ramphal, M Bolger, D J Oblon, et al.

The New England Journal of Medicine|October 10, 1996

A trial comparing nucleoside monotherapy with combination therapy in HIV-infected adults with CD4 cell counts from 200 to 500 per cubic millimeter. AIDS Clinical Trials Group Study 175 Study TeamS M Hammer, D A Katzenstein, M D Hughes, et al.

AIDS (London, England)|July 14, 2000

A randomized study of antiretroviral management based on plasma genotypic antiretroviral resistance testing in patients failing therapy. CPCRA 046 Study Team for the Terry Beirn Community Programs for Clinical Research on AIDSJ D Baxter, D L Mayers, D N Wentworth, et al.

Pageof 30